BBC Homepage
  • Skip to content
  • Accessibility Help
  • Your account
  • Notifications
  • Home
  • News
  • Sport
  • Weather
  • iPlayer
  • Sounds
  • Bitesize
  • CBBC
  • CBeebies
  • Food
  • More menu
More menu
Search BBC
  • Home
  • News
  • Sport
  • Weather
  • iPlayer
  • Sounds
  • Bitesize
  • CBBC
  • CBeebies
  • Food
Close menu
BBC News
Menu
  • Home
  • InDepth
  • Israel-Gaza war
  • War in Ukraine
  • Climate
  • UK
  • World
  • Business
  • Politics
  • Culture
More
  • Tech
  • Science
  • Health
  • Family & Education
  • In Pictures
  • Newsbeat
  • BBC Verify
  • Disability
  • BBC Trending

Drug company stung by criticism of 'outrageous' EpiPen price rises

  • Published
    25 August 2016
Share page
About sharing
Child's hands holding EpiPenImage source, AFP
By BBC Trending
What's popular and why

The pharmaceutical company that makes EpiPens has said it will reduce the cost for some US users, after coming under mounting criticism for a series of price hikes, which have seen the market rate of the potentially life-saving treatment for allergic reactions increase by around five times in less than a decade.

The dramatic rises in the American price for the auto-injector has led to some patients and their relatives using social media to share advice on how to order the device from New Zealand, where it is significantly cheaper.

This week the topic became an election issue when Democratic presidential candidate Hillary Clinton used her social media accounts to describe the behaviour of the drug company, Mylan, as "outrageous" and "just the latest troubling example of a company taking advantage of its consumers."

Clinton tweet objecting to price risesImage source, Hillary Clinton/Twitter

"Millions of Americans with severe allergies rely on their EpiPens. When an allergic reaction leads to anaphylactic shock, a shot of epinephrine can literally be the difference between life and death. But now, just as parents are about to send kids with severe food and insect allergies back to school, the EpiPen's manufacturer is hiking its price to an all-time high," she said in a statement on Facebook, external.

The drugs company has come under fire from leading politicians of both main parties. Though one who has so far not commented is West Virginia Senator Joe Manchin, a Democrat, who is the father of Mylan's CEO, Heather Bresch - a family connection which some on social media have highlighted.

A graphic explains that the CEO of Mylan who makes EpiPens is related to a Senator.Image source, Imgur
Image caption,

Some social media users have been creating graphics to point out that Mylan's CEO is the daughter of a Democratic senator

Mylan has also been publicly rebuked by the Sex & The City actress Sarah Jessica Parker, who had previously endorsed EpiPens when she spoke about her son's peanut allergy. Announcing in an Instagram post that she was ending her association with the company, she wrote: "I hope they will seriously consider the outpourings of voices of those millions of people who are dependent on the device, and take swift action to lower the price."

Sarah Jessica Parker Intsgram post ending association with MylanImage source, Sarah Jessica Parker/Instagram

EpiPens are a simple way to deliver a single dose of the hormone epinephrine (more commonly known as adrenaline) which is used to treat potentially life threatening anaphylactic shocks. Epinephrine itself is not an expensive drug, and it can be administered via syringe. But there are concerns that loading and injecting the correct dose can not only take more time in an emergency situation, but can also be potentially dangerous if administered incorrectly. EpiPens are seen as a safe delivery method as they are pre-loaded with a regulated amount of the drug.

Yet the precise measurement that the EpiPen provides is under patent protection, restricting cheaper generic alternatives from being brought onto the market. As a result, the company has been widely criticised online for its pricing policies and Heather Bresch. One online petition, external asking Mylan to lower the price of EpiPens has gained more than 80,000 signatures.

The US price of the pens has risen, from $100 for a pack of two wholesale in 2008 to about $600 this year. While differences in insurance policies vary how much each family will pay for EpiPens, many social media users who need pens available in multiple locations have said this increased cost has proved to be too expensive for them.

A hand holds the box of an EpiPen Auto-injector which they have just unwrapped.Image source, Imgur
Image caption,

An Imgur user documents their EpiPen purchase arriving from New Zealand

Earlier this week a woman posted, external on the photo-sharing platform Imgur, advising others how EpiPens could be more cheaply acquired online from New Zealand. In the post, which was viewed more than 100,000 times in the space of a few hours, she recounted how she had been able to buy a single pen for around $120. One user wrote: "Thank you so much for this. I had no clue what to do about my son's EpiPens which we could no longer afford. You may have saved a 3-year-old's life".

Mylan's share price has taken a battering as a result of the negative publicity. But it has now rallied after the company announced on Thursday that it would help reduce the out-of-pocket cost of EpiPens by extending its discount programme to more uninsured and underinsured patients. However, it has not reduced the list price of the item. It is not yet clear how many patients this will help.

In a company statement, external, Heather Bresch said: "We recognize the significant burden on patients from continued, rising insurance premiums and being forced increasingly to pay the full list price for medicines at the pharmacy counter. Patients deserve increased price transparency and affordable care, particularly as the system shifts significant costs to them. However, price is only one part of the problem that we are addressing with today's actions. All involved must also take steps to help meaningfully address the U.S. healthcare crisis, and we are committed to do our part to drive change in collaboration with policymakers, payors, patients and healthcare professionals."

Blog by Kate Lamble

NEXT STORY: Liberté, Egalité, Burkini?

To cover or uncoverImage source, @khalidalbaih
Image caption,

"In the name of freedom, while others in the name of religion" is the caption of this drawing by a Qatari artist

Social media debates what the burkini ban says about French values. READ MOREYou can follow BBC Trending on Twitter @BBCtrending, external, and find us on Facebook, external. All our stories are at bbc.com/trending.

Top stories

  • Man, 76, remanded over 'drug-laced sweets' at camp

    • Published
      4 hours ago
  • Steve Rosenberg: Russia is staying quiet on Trump's nuclear move

    • Published
      4 hours ago
  • Car finance judgement 'a hard pill to swallow'

    • Published
      16 hours ago

More to explore

  • What to do if your planned holiday destination is affected by wildfires

    Wildfires seen in July in Chalkida on the Greek island of Euboea
  • Shapewear for your face while you sleep. Has Kim Kardashian taken it too far?

    Two women wearing a face wrap that goes under their chins to the top of their heads
  • Love Island finale, and Wednesday returns: What’s coming up this week?

    A composite image of Maya Jama and the Wednesday Adams character
  • 'Like being with a rock star' - departing Son's 10 years at Spurs

    • Attribution
      Sport
    Son Heung-min celebrates after Tottenham win the Europa League
  • North Korea sent me abroad to be a secret IT worker. My wages funded the regime

    A graphic showing a man in a cap and uniform working on a laptop with a North Korean flag as a background
  • I've seen her name and photo - but we can't talk before the date. Will it work out?

    Alex waiting outside a bar with a cocktail
  • Car loan scandal payouts row - what's it about?

    Man and a woman in smart clothing talk in a car dealership, standing between new cars
  • When Scotland was the world's UFO hot spot

    Two people standing with their backs to us at night. They are high up, overlooking a landscape of lights and water in the distance. The moon is high and the whole night sky is green-tinged and eerie.
  • Summer Essential: Your family’s guide to the summer, delivered to your inbox every Tuesday

    concentric circles ranging from orange to yellow to represent the sun, with a blue sky background
loading elsewhere stories

Most read

  1. 1

    Man, 76, remanded over 'drug-laced sweets' at camp

  2. 2

    Steve Rosenberg: Russia is staying quiet on Trump's nuclear move

  3. 3

    Dua Lipa granted Kosovo citizenship

  4. 4

    Man, 27, drowns saving two nieces at waterfall

  5. 5

    I no longer identify as Nigerian, Badenoch says

  6. 6

    Car finance judgement 'a hard pill to swallow'

  7. 7

    Murdered mum and children died in 'cruel and vicious manner', family say

  8. 8

    Long delays for passengers at Port and LeShuttle

  9. 9

    I've seen her name and photo - but we can't talk before the date. Will it work out?

  10. 10

    Shapewear for your face while you sleep. Has Kim Kardashian taken it too far?

BBC News Services

  • On your mobile
  • On smart speakers
  • Get news alerts
  • Contact BBC News

Best of the BBC

  • A new disappearance reopens old wounds

    • Attribution
      iPlayer
    The Gone
  • Inside DOOM, the controversial 90s game

    • Attribution
      Sounds
    Witness History: The Release of DOOM
  • A classic, nostalgic time-travel adventure

    • Attribution
      iPlayer
    Back to the Future
  • What do your dreams say about you?

    • Attribution
      Sounds
    The Dream Team with Vinny and Cate
  • Home
  • News
  • Sport
  • Weather
  • iPlayer
  • Sounds
  • Bitesize
  • CBBC
  • CBeebies
  • Food
  • Terms of Use
  • About the BBC
  • Privacy Policy
  • Cookies
  • Accessibility Help
  • Parental Guidance
  • Contact the BBC
  • Make an editorial complaint
  • BBC emails for you

Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.